BAROZZI, Patrizia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.057
EU - Europa 8.858
AS - Asia 7.928
SA - Sud America 1.017
AF - Africa 185
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 9
Totale 38.075
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.778
GB - Regno Unito 3.104
CN - Cina 2.247
SG - Singapore 2.240
IT - Italia 1.794
HK - Hong Kong 1.067
SE - Svezia 913
VN - Vietnam 821
BR - Brasile 769
DE - Germania 673
FI - Finlandia 587
UA - Ucraina 398
RU - Federazione Russa 396
FR - Francia 353
TR - Turchia 328
BD - Bangladesh 228
KR - Corea 224
IN - India 219
BG - Bulgaria 153
CA - Canada 134
NL - Olanda 102
ID - Indonesia 95
AR - Argentina 82
MX - Messico 76
JP - Giappone 65
IQ - Iraq 57
BE - Belgio 49
ZA - Sudafrica 48
PL - Polonia 45
ES - Italia 44
AE - Emirati Arabi Uniti 42
CZ - Repubblica Ceca 40
EC - Ecuador 39
IE - Irlanda 39
IR - Iran 38
CO - Colombia 36
PK - Pakistan 31
CL - Cile 30
AT - Austria 29
LT - Lituania 29
PH - Filippine 29
BZ - Belize 26
MA - Marocco 24
VE - Venezuela 22
AZ - Azerbaigian 21
KE - Kenya 21
MY - Malesia 21
UZ - Uzbekistan 21
EG - Egitto 18
RO - Romania 18
DZ - Algeria 16
EU - Europa 16
PY - Paraguay 16
SA - Arabia Saudita 16
TN - Tunisia 16
JO - Giordania 14
NP - Nepal 12
CY - Cipro 11
CH - Svizzera 9
DK - Danimarca 9
ET - Etiopia 9
IL - Israele 9
JM - Giamaica 9
SK - Slovacchia (Repubblica Slovacca) 9
TH - Thailandia 9
TW - Taiwan 9
UY - Uruguay 9
AL - Albania 8
AU - Australia 8
PT - Portogallo 8
CR - Costa Rica 7
PE - Perù 7
PS - Palestinian Territory 7
RS - Serbia 7
BO - Bolivia 6
GR - Grecia 6
KZ - Kazakistan 6
QA - Qatar 6
DO - Repubblica Dominicana 5
EE - Estonia 5
KG - Kirghizistan 5
MD - Moldavia 5
NG - Nigeria 5
NI - Nicaragua 5
OM - Oman 5
PA - Panama 5
SY - Repubblica araba siriana 5
BY - Bielorussia 4
LB - Libano 4
LV - Lettonia 4
SI - Slovenia 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BN - Brunei Darussalam 3
HU - Ungheria 3
MK - Macedonia 3
SN - Senegal 3
SV - El Salvador 3
A2 - ???statistics.table.value.countryCode.A2??? 2
Totale 38.024
Salva come PNG Salva come JPEG
Città #
Southend 2.310
Fairfield 1.978
Ashburn 1.929
Santa Clara 1.580
Singapore 1.434
Woodbridge 1.279
Hong Kong 1.055
Chandler 955
Houston 955
Ann Arbor 820
Jacksonville 783
Hefei 771
Seattle 739
Wilmington 696
Dearborn 655
San Jose 601
Cambridge 589
Nyköping 504
Helsinki 417
London 381
Beijing 380
Los Angeles 367
Chicago 361
New York 313
Modena 297
Ho Chi Minh City 273
The Dalles 261
Council Bluffs 254
Seoul 205
Izmir 190
Milan 179
Hanoi 178
Buffalo 164
San Diego 163
Princeton 149
Sofia 149
Eugene 139
Salt Lake City 127
Lauterbourg 119
Dallas 116
Moscow 107
Munich 107
Fremont 89
Rome 81
Shanghai 76
São Paulo 74
Bremen 71
Des Moines 70
Bologna 61
Tampa 61
Columbus 59
Elk Grove Village 57
Boardman 56
Orem 56
Jakarta 54
Tokyo 53
Frankfurt am Main 51
Atlanta 48
Redwood City 48
Da Nang 42
Brussels 40
Haiphong 39
Montreal 39
Philadelphia 38
Dublin 37
Brooklyn 36
Phoenix 35
Chennai 34
Toronto 34
Albuquerque 32
Boston 32
Turku 31
Lancaster 29
Denver 28
Las Vegas 28
Johannesburg 27
Kent 27
Warsaw 27
Belize City 26
Miami 26
Ottawa 26
Miano 25
Naples 25
Paris 25
Rio de Janeiro 25
Stockholm 24
Guangzhou 23
Nanjing 23
Verona 23
Baghdad 22
Mexico City 22
Norwalk 22
Amsterdam 21
Leawood 21
Reggio Emilia 21
Sterling 21
Dulles 20
Kunming 20
San Mateo 20
Tashkent 20
Totale 27.230
Salva come PNG Salva come JPEG
Nome #
HHV-6A in syncytial giant-cell hepatitis 465
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 442
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 439
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 425
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 419
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 408
B cells and herpesviruses: a model of lymphoproliferation 404
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 397
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 366
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 365
Mucorales-specific T cells in patients with hematologic malignancies 363
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 361
Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors 359
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 357
Acute appendicitis in adult neutropenic patients with hematologic malignancies 356
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 354
Human herpesvirus-8 DNA sequences in Human Immunodeficiency Virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity 353
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 352
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 352
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 350
PCR con primer degenerati non evidenzia sequenze virali di HHV-8 ne di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 350
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 348
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 347
Translational challenges of human herpesvirus 6 chromosomal integration. 345
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 345
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 342
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 341
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 340
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 340
3 CASES OF HUMAN HERPESVIRUS-6 LATENT INFECTION - INTEGRATION OF VIRAL GENOME IN PERIPHERAL-BLOOD MONONUCLEAR CELL-DNA 338
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 324
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 321
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 321
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 319
Dual inhibition of PI3K/mTOR signaling in chemoresistant AMLprimary cells. 316
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 311
Parvoviruses in blood donors and transplant patients, Italy 311
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 311
Angiogenesis in multiple myeloma: Correlation between in vitro endothelial colony growth (CFU-En) and clinical biological features 308
Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma 307
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 307
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 305
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 304
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 299
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 298
Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet 292
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 292
Additional neoplasms and HCV infection in low-grade lymphoma of MALT type 288
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 285
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 284
Diagnosis of aspergillosis: Role of proteomics 284
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 282
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 281
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 280
Successful Treatment of KSHV Inflammatory Cytokine Syndrome (KICS) after Kidney-Liver Transplant: Correlations with HHV8 miRNome and Specific T-Cell Response 277
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 275
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 275
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 274
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 273
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 271
Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo 271
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 265
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 265
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 263
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 262
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 262
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 260
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 259
Late-appearing PML/RAR alpha fusion transcript with coincidental t(12;13)(p13.2;q14) in acute promyelocytic leukemia lacking the t(15;17) cytogenetic anomaly 254
How I treat HHV8/KSHV-related diseases in posttransplant patients. 253
The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign 253
HHV-8 infection in the transplantation setting: A concern only for solid organ transplant patients? 252
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 251
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 248
Human herpesvirus-8 infection in hemodialysis patients from northern Italy. 247
HHV-8-associated primary cerebral B-cell lymphoma in HIV-negative patient after long-term steroids 246
Cellular localization of human herpesvirus 8 in nonneoplastic lymphadenopathies and chronic interstitial pneumonitis by in situ polymerase chain reaction studies 246
HUMAN HERPESVIRUS-6 - A SURVEY OF PRESENCE AND DISTRIBUTION OF GENOMIC SEQUENCES IN NORMAL BRAIN AND NEUROGLIAL TUMORS 245
Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients 244
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 243
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 242
KNOCK-DOWN DI BLIMP1/PRDM1 IN CELLULE PEL MEDIANTE siRNA; OTTIMIZZAZIONE DEL SISTEMA DI TRANSFEZIONE E STUDI IN VITRO 240
Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission 239
Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor 237
Metodo per la diagnosi e/o il monitoraggio dell’ aspergillosi invasiva 236
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 234
Kaposi's sarcoma triggered by endogenous HHV-8 reactivation after non-myeloablative allogeneic haematopoietic transplantation 231
Human herpesvirus-6 (HHV-6) in blood donors 230
Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia 230
Polymerase chain reaction detection of human herpesvirus 8 sequences in primary central nervous system lymphomas 227
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 226
Human herpesvirus 6 infection in normal human brain tissue 224
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 220
CHARACTERIZATION OF HUMAN HERPESVIRUS-6 GENOMES FROM CASES OF LATENT INFECTION IN HUMAN LYMPHOMAS AND IMMUNE DISORDERS 218
Lymphotropic herpes virus (EBV, HHV-6, HHV-8) DNA sequences in HIV negative Castleman's disease 218
Is it now the time to update treatment protocols for lymphomas with new anti-virus systems? 213
Human herpesvirus-6 reactivation in a longitudinal study of two HIV-1 infected patients 210
Fatal hemophagocytic syndrome related to active human herpesvirus-8/Kaposi sarcoma-associated herpesvirus infection in human immunodeficiency virus-negative, non-transplant patients without related malignancies 208
Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily. 208
Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies 207
Totale 29.585
Salva come PNG Salva come JPEG
Categoria #
all - tutte 143.486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 143.486
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021194 0 0 0 0 0 0 0 0 0 0 0 194
2021/20222.760 76 381 381 171 57 98 181 136 264 189 505 321
2022/20232.915 391 322 173 284 429 388 75 277 298 36 148 94
2023/20241.938 66 110 137 167 410 206 218 284 35 38 85 182
2024/20255.820 248 71 101 426 1.053 832 454 324 609 240 617 845
2025/202611.118 814 507 1.072 1.219 1.812 877 1.346 564 1.110 949 716 132
Totale 38.366